CD226 AGONIST ANTIBODIES

The present invention relates to anti-human CD226 agonist antibodies, which can be useful for treating solid tumor cancers. 本发明涉及可以用于治疗实体瘤癌症的抗人CD226激动剂抗体。

Saved in:
Bibliographic Details
Main Author KUMAR NISHCHAY
Format Patent
LanguageChinese
English
Published 16.03.2021
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to anti-human CD226 agonist antibodies, which can be useful for treating solid tumor cancers. 本发明涉及可以用于治疗实体瘤癌症的抗人CD226激动剂抗体。
Bibliography:Application Number: CN201980049410